In Phase 2 trials (the TRIUMPH-2 study involving 338 participants over 48 weeks), the 12 mg dose of Retatrutide produced an average weight loss of 24.2%
No, she had posted a photo of herself on Instagram, wearing a black dress and heels outside a house (presumably hers), in front of a wooden circle decorated with garlands of roses
Read the full paper: Completely expected result: Working for 20 years with these patients and looking at scientific evidence, the conclusion is: Obesity is a metabolic disease
Overall, 25% participants in the placebo group discontinued the study compared with 14.3% (5 mg), 16.4% (10 mg), 15.1% (15 mg) in the treatment groups
Wegovy and its sister drug for Type 2 diabetes, Ozempic, as well as a similar drug from Eli Lilly called Mounjaro, have been transforming the way doctors approach weight loss with medicines after decades of drugs with weak efficacy and dangerous safety issues